Clinical Trial Update: Prostacyclin's Effect on Platelet Responsiveness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating prostacyclin's effect on platelet responsiveness in acute kidney injury has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Prostacyclin (epoprostenol)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Acute Kidney Failure | Phase 4 | Status: COMPLETED